A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants
A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants
Recruiting · NCT07727538 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants | familial chylomicronemia syndrome, familial lipoprotein lipase deficiency | Recruiting | Phase 3 | 2026-10-08 | NCT07727538 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ionis Pharmaceuticals, Inc. | 22 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cook Children's Medical Center | Fort Worth | United States | 111 |
| Mary Bridge Children's | Tacoma | United States | 1 |
| UCSF Benioff Children's Hospital | San Francisco | United States | 5 |
| University of Alabama | Birmingham | United States | 29 |
| University of Texas Southwestern Medical Center | Dallas | United States | 249 |